1-3 of 3
Penglie Zhang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone disease

Daniel J. Dairaghi, Babatunde O. Oyajobi, Anjana Gupta, Brandon McCluskey, Shichang Miao, Jay P. Powers, Lisa C. Seitz, Yu Wang, Yibin Zeng, Penglie Zhang, Thomas J. Schall, Juan C. Jaen
Journal: Blood
Blood (2012) 120 (7): 1449–1457.
https://doi.org/10.1182/blood-2011-10-384784
Published: 2012
Includes: Supplemental data
Journal Articles

CCR1 Blockade by An Orally-Available CCR1 Antagonist Reduces Tumor Burden and Osteolysis In Vivo In a Mouse Model of Myeloma Bone Disease

Babatunde Oyajobi, MD, PhD, Daniel Dairaghi, PhD, Anjana Gupta, Brandon McCluskey, Yu Wang, Lisa C. Seitz, Jay P. Powers, PhD, Shichang Miao, PhD, Penglie Zhang, PhD, Thomas J. Schall, PhD, Juan C. Jaen, PhD
Journal: Blood
Blood (2010) 116 (21): 3000.
https://doi.org/10.1182/blood.V116.21.3000.3000
Published: 2010
Journal Articles

Inhibition of Prothrombinase and Not Soluble Factor Xa (fXa) Predicts Efficacy of fXa Inhibitors in an In Vivo Model of Deep Vein Thrombosis.

Suzanne Delaney, Ann Arfsten, Sherin Halfon, Gail Siu, John Malinowski, Penglie Zhang, Shaun Bauer, Zhaozhong Jia, Bingyan Zhu, Gary Park, Stanley Hollenbach, Uma Sinha
Journal: Blood
Blood (2006) 108 (11): 902.
https://doi.org/10.1182/blood.V108.11.902.902
Published: 2006